Genetic tests showed that certain patients were predisposed to brain injuries if they took the drugs. That information ...

Britain’s drug regulator approved the Alzheimer’s drug Kisunla on Wednesday, but the government won’t be paying for it after ...

In the heart of Seattle, some of the world’s most brilliant minds study the brain at the Allen Institute, where researchers ...

Alzheimer's disease may damage the brain in two distinct phases, based on new research using sophisticated brain mapping ...

As our family members age, we worry. We worry about their physical health and potential cognitive declines. If you are ...

New details have emerged into how Alzheimer’s disease affects the brain. Researchers have identified cellular changes in the ...

An analysis of the genetic activity of brain cells in individuals who have died with Alzheimer's disease has revealed the ...

New disease-modifying Alzheimer’s drugs work best when they are given to patients in the early stages of disease. The drug has been licensed for use in the UK but rejected by the NHS spending watchdog ...

Rensselaer Polytechnic Institute (RPI) has been awarded two grants by the National Institute on Aging (NIA) to train graduate ...

A recent study suggests that a drug approved for the treatment of seizures may also help treat Alzheimer's in people who do ...

Alzheimer's disease might damage the brain in two distinct phases, a new study suggests. An early phase that occurs slowly ...